Medical Oncologist
Olaparib (Lynparza) · Timeline
How Long Does Olaparib — Take to Work?
You have just been prescribed olaparib and you want to know when you will see a difference. The answer depends on what kind of response your team is watching for — and that is not the same for everyone on this drug.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Working from day one — Olaparib begins blocking PARP enzymes in cancer cells from your first tablet. You will not feel this, but it is happening.
- First response check at 8–12 weeks — The first formal imaging assessment is usually scheduled around 8 to 12 weeks after starting.
- Stable disease is a success — If you are on olaparib as maintenance therapy, holding disease steady is the goal — not necessarily tumour shrinkage.
- Symptoms are not a reliable signal — How you feel does not tell you whether olaparib is working. Your team uses scans and blood tests to judge response.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Olaparib begins working at the cellular level from your first tablet. But measurable response — a stable or shrinking tumour on a scan — is not assessed until around 8 to 12 weeks into treatment. If you are on maintenance therapy, the goal is stability, not shrinkage, and that picture takes the same time to emerge.
What happens week by week on olaparib?
Days 1–14: The drug enters your system
Olaparib is absorbed within hours of each tablet. From the first dose, it begins blocking PARP enzymes inside cancer cells, preventing them from repairing their own damaged DNA. You are not expected to feel anything different yet.
Weeks 2–4: Side effects, if any, usually appear
Nausea, fatigue and low appetite are the most common early effects. They often settle after the first month. Your team will check your blood counts in this window, because olaparib can reduce red blood cells and platelets in some people.
Weeks 4–8: Tumour markers may begin to shift
If your team is monitoring a marker such as CA-125 or PSA, it may start to change in this period. A falling marker is an encouraging early signal. A marker that holds steady is not failure — particularly if you are on olaparib as maintenance therapy.
Weeks 8–12: First formal response assessment
Most oncologists schedule imaging — a CT scan or equivalent — around 8 to 12 weeks into treatment. This is when your team can formally say whether disease has shrunk, stayed stable, or progressed. It is the earliest reliable picture of how olaparib is working for you.
Beyond 12 weeks: Regular monitoring continues
Response is reassessed at scheduled intervals throughout treatment. Olaparib often works by holding disease stable over many months, so no single scan is the complete picture. Monitoring continues for as long as you are on treatment.
What does 'working' actually mean on olaparib?
For most treatments, working means the tumour visibly shrinks. Olaparib does not always work that way, and this causes a lot of confusion.
If you are taking olaparib as maintenance therapy — to keep a disease that has already responded from coming back — then stable disease is the definition of success. The absence of growth on your scan is what your oncologist is watching for, and that is a meaningful outcome.
If you are taking olaparib to treat active disease, your team is watching for shrinkage or disease control. Your first scan gives an early answer, but response often deepens over subsequent months.
Can you tell if olaparib is working by how you feel?
Not reliably. Olaparib works at the level of DNA repair inside individual cancer cells. There is no sensation associated with that process — no feeling of the drug targeting tumour tissue.
Feeling fatigued or nauseated does not mean the drug is working. Feeling well does not mean it is failing. Side effects and effectiveness are separate questions with separate answers.
Your team uses scans and blood markers to judge response, not how you feel from week to week. Bring your symptom concerns to your appointments separately from your questions about response.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
When should you call your team before the scheduled scan?
Waiting for your 8 to 12 week scan is appropriate for most people. But some changes should not wait that long.
Call your oncology team the same day if you develop new pain that is different from your usual pattern, significant shortness of breath, signs of infection such as fever, or heavy fatigue that stops you getting through the day.
These may not mean the treatment has stopped working, but your team needs to hear about them promptly rather than at your next scheduled visit.
Questions families ask most
My CA-125 went up slightly after starting olaparib. Does that mean it is not working?
A small rise in CA-125 in the first few weeks does not reliably predict how treatment will go. Tumour markers can fluctuate for reasons unrelated to treatment effect — including inflammation, the tumour shedding antigen as cells die, or normal assay variation. A single value at one point in time is not how your team makes a decision. They look at the trend across several readings, always in the context of your imaging. Bring your concern to your next appointment and ask your oncologist to walk you through the trend rather than interpreting a single number on your own.
Can olaparib stop working after it has been effective for a while?
Yes, this can happen. It is called acquired resistance, and it occurs when cancer cells develop new ways to repair their DNA despite the drug blocking PARP. It is not a failure on your part, and it is not something that happens without warning — your team monitors for it with regular scans and markers precisely because they know it is possible. If resistance develops, your oncologist will discuss what the next step is. There are established options beyond olaparib, and reaching them is not the same as running out of choices.
What does the team do if the 8-week scan shows no change?
Stable disease — no change — is often the intended outcome on olaparib, especially in the maintenance setting. Your oncologist will not automatically stop treatment because the tumour has not shrunk; that may be exactly what they were hoping to see. What they are ruling out is progression — clear growth or new spread. If the scan shows stable disease, the most common decision is to continue and reassess at the next scheduled interval. Your team will explain what the result means in the context of why you are on olaparib.
Does it matter if I miss a dose or take it at an irregular time?
Olaparib is taken twice a day to maintain steady levels in your bloodstream, and consistency matters. If you miss a dose, do not double the next one — just continue as normal and note it in your diary. If you frequently miss doses or have trouble with the schedule, tell your pharmacist or oncology nurse, because there are practical strategies that can help. The timing of each dose does not need to be exact to the minute, but taking both daily doses every day is important for the drug to do its job consistently.
Can herbal supplements or traditional medicines affect how olaparib works?
Some herbal products and traditional preparations can interfere with the enzymes that process olaparib in your liver, changing the level of drug in your bloodstream — either reducing it so it is less effective, or raising it so side effects become worse. St John's Wort is one well-documented example, but it is not the only one. Tell your oncology team and your pharmacist everything you are taking, including anything bought without a prescription or prepared at home. They will not judge you for it — they need to know in order to keep you safe.
Did you know?
Olaparib exploits a vulnerability that exists only in cells with BRCA mutations — a principle called synthetic lethality. Normal cells have a backup DNA repair pathway that BRCA-mutated cancer cells have permanently lost.
This is why eligibility testing for a BRCA mutation is required before olaparib is prescribed. Without that mutation, the mechanism that makes the drug selective is absent.
Source: ESMO Clinical Practice Guidelines — Ovarian Cancer; NCCN Guidelines for BRCA-Related Cancers
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How will my doctor know if olaparib is working?
Your oncologist uses imaging — usually a CT scan — alongside blood-based tumour markers such as CA-125 or PSA, depending on your cancer type. The first formal assessment is usually around 8 to 12 weeks into treatment. They look at whether the disease has shrunk, stayed stable, or progressed. In the maintenance setting, stability is the success criterion, not shrinkage. Your team will explain what each result means for your specific situation.
Is it normal to feel no different after starting olaparib?
Yes. Olaparib works at the cellular level, blocking DNA repair inside cancer cells. There is no sensation associated with that process. Many people notice little change in the first weeks — or the main change is from side effects rather than any sense of the drug targeting tumour tissue. Feeling unchanged is not a sign that olaparib is failing. Your team uses objective measures, not how you feel, to judge response.
How long do people usually stay on olaparib?
It depends on why you are taking it and how your disease responds. In the maintenance setting, guidance from NCCN and ESMO generally supports continuing olaparib for as long as it is keeping disease under control and side effects are manageable. In the treatment setting, duration is guided by response seen on regular imaging. Your oncologist will review this at each scheduled assessment and discuss the plan with you.
Can blood tests show whether olaparib is working, or do I need a scan?
Blood-based tumour markers can give an early indication, but they are not conclusive on their own. A falling CA-125 or PSA can be an encouraging early signal; a rising marker warrants discussion with your team. Markers can also fluctuate for reasons unrelated to olaparib's effect on the tumour. Imaging gives a more reliable picture of what the disease is actually doing. Your team uses both together, not one in isolation.
What should I do if I feel worse after starting olaparib?
Tell your oncology team. Feeling worse does not automatically mean treatment is not working — it may mean a side effect needs managing. Fatigue and nausea are common in the first weeks and often improve. Worsening pain, fever, significant shortness of breath, or new symptoms that feel different from what you had before starting should be reported the same day rather than waited on. Your team cannot adjust your care without knowing what you are experiencing.
Is olaparib available at CION, and how is it given?
Olaparib is a tablet taken at home twice a day — it is not an infusion, so you do not come in for each dose. CION coordinates the prescribing, monitoring and response assessment for patients on olaparib across its centres in Telangana and Andhra Pradesh. CT and PET-CT scans for response assessment are arranged through partner imaging centres. Your oncologist and pharmacist will explain the schedule and what to expect at each review appointment.